The pathophysiology of lipedema and its linkage to mobility impairments is complex, involving multiple physiological systems. Lipedema is characterized by the abnormal accumulation of adipose tissue, particularly in the lower limbs, which can significantly hinder physical movement. The disproportionate fat distribution primarily around the thighs, hips, and lower legs alters the biomechanical alignment and load distribution across the joints, subsequently increasing the risk of joint degeneration and pain, notably in the knees and hips. Moreover, the excess fat often leads to secondary lymphatic overload and dysfunction because the lymphatic system becomes overwhelmed and incapable of efficiently managing lymph fluid. This lymphatic impairment contributes to tissue swelling and fibrosis, which not only exacerbates the physical bulk of the limbs but also stiffens the tissues, further restricting joint mobility and agility. Additionally, the pathological changes in connective tissue seen in lipedema—increased fibrosis and reduced elasticity—can impair the normal range of motion and elasticity of the skin and connective tissue, leading to a decreased functional capability. These factors combined significantly impair the ability to perform daily activities, contributing to a reduced quality of life and increased disability in individuals with lipedema.